Pointers for Would-Be Bioentrepreneurs; British Biologists Finally Bond; PhD Salaries by Age

TIP TROVE | Pointers for Would-Be Bioentrepreneurs Courtesy of Mark Tang 1. Work with experts. Look for help and good advice early on from lawyers (intellectual property and corporate), business advisers, and venture capitalists (VCs). 2. Get FREE money and take as much money as you can get. But keep the number of investors who expect a cut to the minimum. Seek out grants and big pharmaceutical partners. You may need more money than you think. 3. Aim for proprietary technology, platform t

Written byMark Tang
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

TIP TROVE | Pointers for Would-Be Bioentrepreneurs

1. Work with experts. Look for help and good advice early on from lawyers (intellectual property and corporate), business advisers, and venture capitalists (VCs).

2. Get FREE money and take as much money as you can get. But keep the number of investors who expect a cut to the minimum. Seek out grants and big pharmaceutical partners. You may need more money than you think.

3. Aim for proprietary technology, platform technology, or a portfolio of technologies to attract VC interest. Remember, a patent alone does not make a company.

4. Work hard on the business model. Your business model will determine your survival. VCs look for a hybrid business model that combines platform technology with therapeutics.

5. Keep the burn rate low and the cash balance high. A blockbuster drug can take 12-16 years to develop.

--Mark Tang is author of The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies